EP Patent

EP0996459B1 — Use of exendins and agonists thereof for the reduction of food intake

Assigned to AstraZeneca Pharmaceuticals LP · Expires 2005-09-21 · 21y expired

What this patent protects

A pharmaceutical composition comprising an exendin or an exendin agonist peptide and a buffer, wherein said composition has a pH of from 3.0 to 8.0, provided that the composition is not suspended in an aqueous buffer at a pH of about 5.6 to 7.4.

USPTO Abstract

A pharmaceutical composition comprising an exendin or an exendin agonist peptide and a buffer, wherein said composition has a pH of from 3.0 to 8.0, provided that the composition is not suspended in an aqueous buffer at a pH of about 5.6 to 7.4.

Drugs covered by this patent

Patent Metadata

Patent number
EP0996459B1
Jurisdiction
EP
Classification
—
Expires
2005-09-21
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca Pharmaceuticals LP
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.